Hydrogen Therapy Boosts Immune Recovery After Brain Surgery
Molecular Hydrogen Therapy Enhances Immune Markers in Treg, Plasma, Tr1 Cells, and KLRG1 Expression on Tc Cells: A Case of Acute SDH With Midline Shift and Uncal Herniation Post-decompressive Craniectomy
Research hubs: Brain & Nervous System · Immune System
- Evidence type
- Case report or series · Human study
- Authors
- HUI-FU HSU, RUEI-YANG HU, JENG-WEI LU, DUENG-YUAN HUENG, YI-JUNG HO, SHAN-WEN LUI, TING-YU HSIEH, KUANG-YIH WANG, HSIAO-CHEN LIU, FENG-CHENG LIU
- Journal
- In Vivo
- Year
- 2025
- PMID
- 40010997
- Study Type
- Human
- Participants
- 1
- Delivery
- Gas
- Dose
- hydrogen capsules, daily treatment beginning upon admission
- Funding
- Ministry of Science and Technology (MOST 111-2314-B-016-026); National Science and Technology Council (NSTC 112-2314-B-016-033); National Science and Technology Council (NSTC 113-2314-B-016-052); Tri-Service General Hospital (TSGH-E-111215); Tri-Service General Hospital (TSGH-E-112218)
- Conflicts of interest
- None declared
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- Taiwan
TL;DR
A young man with a serious brain injury showed potential benefits from a new treatment using hydrogen capsules, which seemed to help his immune system without causing harm.
Key Finding
In this single patient case, hydrogen therapy appeared to enhance certain immune markers without causing adverse effects, though standard emergency treatments were the primary drivers of recovery.
Summary
This case report describes a 24-year-old man who survived a severe brain bleed (subdural hematoma) with life-threatening complications after receiving standard emergency treatments plus hydrogen capsules. Researchers measured immune system markers in his blood and found that certain immune cells (regulatory T cells and plasma cells) showed changes that might suggest hydrogen therapy enhanced immune function, though the patient's recovery was primarily due to conventional treatments like surgery and oxygen therapy.
Practical Takeaway
This is a single case report of one patient receiving hydrogen alongside multiple intensive medical interventions for a life-threatening condition—it cannot establish whether hydrogen itself provided benefit. While the immune marker changes are interesting, much larger controlled studies are needed before any conclusions can be drawn about hydrogen's role in treating brain bleeds. This case is too limited to inform personal health decisions.
Abstract (excerpt)
Background/aim: Subdural hematomas (SDH), often caused by head trauma, are serious with high mortality and long-term complications. Studies show that molecular hydrogen has neuroprotective effects, such as reducing oxidative stress, inflammation, and cell death. It may also protect mitochondria…